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During 2012 about 59,000 new cases of cancer will be diagnosed among Ohio residents. About 25,000 

Ohioans will die this year with cancer as the underlying cause of death. In the U.S., and in Ohio, men and 

women have about a 1 in 3 lifetime risk of developing some type of invasive cancer.
 
You undoubtedly know someone who has been affected by cancer – a family member, friend, co-worker, 





In 2011 the Ohio Partners for Cancer Control, Ohio’s statewide comprehensive cancer control partnership, 

recognized the need to reduce the cancer burden and created The Ohio Comprehensive Cancer Control 

Plan 2011-2014. Created with the collaboration of more than 20 organizations the Plan serves as a 

blueprint for cancer surveillance, prevention, screening and early detection, clinical trials, palliative care, 

and survivorship. The Plan includes objectives that were initiated in 2011, even as the plan was being 

developed. New organizations are continually encouraged to join and work toward completing the 

objectives and/or add new objectives to this dynamic plan.
 
The pathway to improved cancer surveillance, prevention, and control will not be easy. Cancer is rarely 

caused by just one factor and has a long latency period making identification of causes difficult. But we do 

know that healthy diets, plenty of exercise, and tobacco use prevention and cessation will greatly reduce 

the burden of cancer. Following age and gender appropriate screening guidelines will help us all find 

cancer at its earliest and most treatable stages. We must all work together to improve the quality of life for 

cancer survivors and their loved ones.
 
Thank you for using and sharing the The Ohio Comprehensive Cancer Control Plan 2011-2014. The Ohio 

Partners for Cancer Control invites you to learn more about our efforts and to join us as we work toward “a 

cancer-free future for all Ohioans”.
 
Sincerely, 
Jeff Lycan, Chair 
President/CEO 
Midwest Care Alliance 
855 South Wall Street 
Columbus, OH 43206 
(614) 763-0036 
 
John Hoctor, Vice-Chair 
Vice President of Government 
Relations 
American Cancer Society 
East Central Division 
5555 Frantz Road 
Dublin, Ohio 43017 
(888) 227-6446  
Robert Indian, 
Acting Executive Director 
Chief, Comprehensive Cancer 
Control Program 
Ohio Department of Health 
246 North High 
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This publication was prepared by: 
The Ohio Partners for Cancer Control 
c/o Ohio Comprehensive Cancer Control Program 
Ohio Department of Health 
246 North High Street 
Columbus, Ohio 43215 
This publication was supported in part by Cooperative Agreement Number DP07-703 1 U58­
DP000795-05 from the Centers for Disease Control and prevention. Its contents are solely the 
responsibility of the Ohio Partners for Cancer Control and do not necessarily represent the 
official views of the Centers for Disease Control and Prevention. 
The goals and objectives of the Ohio Comprehensive Cancer Control Plan 2011-2014 were 
unanimously approved at the Ohio Partners for Cancer Control General Member meeting of 
April 19, 2012. 
Suggested Citation: 
The Ohio Comprehensive Cancer Control Plan 2011-2014. 
Columbus, Ohio: Ohio Partners for Cancer Control, March 2012. 
Copyright information: 
All materials in this Plan are public domain and may be reproduced  
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DEDICATION 
The Ohio Comprehensive Cancer Control Plan 2011-2014 is dedicated to all Ohioans whose lives 
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THE OHIO COMPREHENSIVE 

CANCER CONTROL PLAN 2011-2014:
 
14 Goals for “A Cancer-Free Future for All Ohioans” 
Data and Surveillance 
GOAL 1: Enhance the Quality and Reporting of Cancer Incidence Data and Increase the 
Dissemination and Use of Data for Cancer Prevention and Control 
Primary Prevention 
GOAL 2: Reduce Tobacco Use among Ohioans 
GOAL 3: Reduce Exposure to Environmental Carcinogens
GOAL 4: Increase the Proportion of Adults and Children who Engage in Recommended 
Physical Activity Levels 
GOAL 5: Increase the Proportion of Adults and Children Who Engage in Healthy Eating 
Behaviors 
GOAL 6: Increase the Vaccination Rate for Vaccines Shown to Reduce the Risk of Cancer 
GOAL 7: Reduce Exposure to Ultraviolet Radiation from the Sun and Sun Lamps 
Screening and Early Detection 
GOAL 8: Improve Screening and Early Detection and Follow-up for Breast, Colorectal, and 
Cervical Cancers 
GOAL 9: Promote the Use of Cancer Genetic Services 
Treatment/Survivorship/Palliative Care 
GOAL 10: Promote Clinical Trials
GOAL 11: Optimize the Quality of Life for Cancer Survivors and Significant Others through 
Community - Based Wellness Programs and Clinical Linkages
GOAL 12: Provide Essential Survivorship Management Tools and Services to Cancer Survivors
GOAL 13: Impact the Quality of Life of Cancer Patients by Providing American Cancer Society 
Information and Referral to National, Local and Community Resources, Programs, and Services 
Advocacy/Communication 
GOAL 14: Increase Interest in Cancer Surveillance, Prevention, and Control Activities among 





















Comprehensive Cancer Control 
The Centers for Disease Control and Prevention (CDC) defines Comprehensive Cancer Control as
“a collaborative process through which a community pools resources to 

reduce the burden of cancer that results in risk reduction, early detection, 

better treatment, and enhanced survivorship.”1
 
CDC created the National Comprehensive Cancer Control Program (NCCCP) to help states, 
tribes, and territories form coalitions to conduct comprehensive cancer control. Ohio received 
funding from CDC in 2002 to establish Ohio’s Comprehensive Cancer Control Program. The 
CDC has identified seven NCCCP priorities for state Comprehensive Cancer Control Programs:1 
1.	 An emphasis on primary prevention, e.g. improved nutrition, increased physical activity, 
smoking prevention and cessation; 
2.	 Coordination of early detection and treatment interventions; 
3.	 Addressing the public health needs of cancer survivors; 
4.	 Implementation of policies to sustain cancer control; 
5.	 Elimination of cancer disparities and achievement of health equity; 
6.	 Use of evidence-based approaches, and 
7.	 Measuring impact through evaluation. 
Comprehensive Cancer Control relies on active involvement by concerned citizens and key 
stakeholders and uses data in a systematic process to: 
•	 Determine the burden of cancer; 
•	 Identify the needs of communities and/or population-based groups; 
•	 Prioritize these needs; 
•	 Develop interventions and infrastructure to address the needs; 
•	 Mobilize resources to implement interventions; and 
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Ohio Partners for Cancer Control 
The Ohio Partners for Cancer Control (OPCC) is a statewide coalition dedicated to reducing 
the burden of cancer in Ohio. The coalition includes representatives of organizations who 
have cancer prevention and control as a focus of their mission. Organizations represented 
include hospitals, universities, cancer centers, health care professional associates, nonprofit 
organizations, government agencies, minority health coalitions, and community organizations. 
The OPCC vision is “A Cancer-Free Future for All Ohioans”. The OPCC stresses a unified fight 
against cancer through collaboration and use of a comprehensive approach. The OPCC seeks 
to be inclusive not exclusive. New members and fresh ideas are always welcome. The OPCC will 
achieve far greater success than could be accomplished by individual organizations working 
alone. The OPCC Membership Enrollment Form (Appendix B) and the OPCC website at 
http://www.ohiocancercontrol.org describe how you can get involved. 
The Ohio Comprehensive Cancer Control Plan 2011-2014 
Ohio’s Comprehensive Cancer Control Plan 2011-2014 (the Plan) is a strategic plan to reduce the 
cancer burden in our state. It is designed to provide guidance to individuals and organizations 
spanning a wide range of health and social disciplines that can play a role in controlling cancer. 
All aspects of the cancer surveillance prevention and control continuum are addressed. These 
aspects include data and surveillance, primary prevention, screening and early detection, 
treatment, quality of life and end-of-life care, and advocacy. 
The Plan has three guiding principles that cut across all 14 goals and related objectives: 
•	 Data driven decisions; 
•	 Evidence based interventions, and 
•	 Identification of disparities and progress toward equity. 
The Plan’s strategies are intended to direct collective efforts toward specific and measurable 
objectives that will reduce the cancer burden. Also, many of the outcomes will have benefits 
extending beyond cancer to other leading chronic diseases. 
Finally, please note that this Plan is meant to be a dynamic document. As opportunities arise, 
funding sources appear, and breakthroughs in prevention, screening, etc., are found, new 
objectives can and will be added. 
Plan Implementation 
With support from the CDC, states, tribes, and territories throughout the nation are working 
to combat cancer through an integrated and coordinated approach to establish cancer 
control infrastructures, develop and implement comprehensive cancer control plans, mobilize 












The Ohio Comprehensive Cancer Control Program (OCCCP) is charged with formulating and 
upholding a consolidated vision for reducing our state’s cancer burden through policy, systems, 
and environmental change initiatives. The OCCCP will lead the development and distribution of 
this Plan, promote the efforts of stakeholders and the OPCC, foster statewide communication 
and collaboration on cancer control issues, and publish evaluation results in order to refine 
cancer control strategies. 
While the OPCC provides the forum for coordination of Ohio’s call to action, the individual 
partners are ultimately the driving force behind the achievement of the Plan’s goals and 
objectives. The implementation of the Plan is the responsibility of all cancer surveillance, 
prevention and control stakeholders. Each objective in the Plan has responsible parties that 
have committed to completing specific objectives with committee members and OPCC 
support. Persons from other organizations are encouraged to join this team at any time. New 
partners are encouraged and needed. Again the OPCC seeks to be inclusive of all persons in 
the execution of this Plan. Only through collective action will Ohio succeed in reducing cancer 
incidence and mortality and improve the quality of life for cancer survivors. 
To assist with plan implementation, the CDC recommends modeling comprehensive cancer 
control activities after evidence-based public health programs:2 
“Evidence-based interventions are programs that have been evaluated as effective  
in addressing a health-specific condition in the context of a particular ethnicity or  
culture. These programs identify the target populations that benefited from the  
program, the conditions under which the program works, and sometimes the 
change mechanisms that account for their effects. They use various tested  
strategies that target a disease or behavior. A defining characteristic of  
evidence-based intervention is their use of health theory both in developing  
the content of the interventions and evaluations.” 
To achieve the goals and objectives presented in the Plan, we need to implement strategies, 
practices, interventions, and/or programs that are grounded in evidence. Below are some 
resources that provide examples and further information about using evidence-based 
programs:
•	 Best Practices for Comprehensive Tobacco Control 
http://www.cdc.gov/tobacco/stateandcommunity/best_practices/index.htm 
•	 Cancer Control P.L.A.N.E.T http://cancercontrolplanet.cancer.gov 
•	 Cochrone Review www.cochrane.org/index.htm 
•	 The Community Guide www.thecommunityguide.org 
•	 Prevention Research Centers www.cdc.gov/prc 
•	 Research-Tested Intervention Programs (RTIP) http://rtips.cancer.gov/rtips/index.do 
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Evaluation 
Program evaluation is the systematic collection of information about a programs processes, 
short-term impacts, and long-term outcomes in order to identify problems, determine if goals and 
objectives are met, guide program improvements, and build on successes. Both quantitative and 
qualitative methods must be used. 
The OCCCP is responsible for developing and implementing an evaluation plan that will assess 
the 2011-2014 Plan and provide data driven revisions of statewide cancer goals and objectives. 
The ultimate long-term measure of the Plan’s success will be the reduction of cancer mortality 
rates in Ohio. However, since long-term outcomes take years to achieve, short-term impacts will 
be assessed through progress on measurable objectives in the Plan. 
Quantitative data obtained from the Ohio Cancer Incidence Surveillance System at the Ohio 
Department of Health (ODH) will measure improvements in cancer incidence and stage of 
diagnosis. Data from the Vital Statistics Program at ODH will be used to measure progress in 
reducing cancer mortality. For progress on objectives related to risk factors and screening, the 
Ohio Behavioral Risk Factor Surveillance System (BRFSS) and other quantitative data sources 
will be used. In addition, a statewide survey of OPCC stakeholders will be conducted each year 
by the OCCCP to collect quantitative and qualitative data on cancer control activities. All of the 
measurable objectives in the Plan will be followed in progress reports using the most reliable and 
recent data to assess cancer control progress, impacts, and outcomes in Ohio. To see a list of all 
data sources used and/or referred to in the Plan, please see Appendix A. 
While the Ohio Comprehensive Cancer Control Program is responsible for evaluating the Plan, 
it is critical that other partners throughout Ohio also participate in monitoring progress and 
use data from available sources to guide their cancer control activities. Challenges are expected 
during the implementation and evaluation of the Plan as a result of shifts in science, healthcare, 
the economy, the environment, funding opportunities, and the political climates. Again, it is 
acknowledged that the Plan is a dynamic document that will evolve with time, new information, 
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THE CANCER BURDEN IN OHIO
 
Cancer is not just one disease but at least 200 different diseases with an underlying pathology 
of runaway growth of abnormal cells.1 If this runaway growth is not controlled it can result in 
death. 
While anyone can develop cancer, the risk increases with age. About 78% of all cancers are 
diagnosed among persons age 55 years and older.1 In the United States, males and females 
have about a 1 in 3 lifetime risk of developing some type of invasive cancer.3 
Cancer incidence data from the Ohio Cancer Incidence Surveillance System (OCISS) and cancer 
mortality data from the Ohio Vital Statistics (VS) Program at ODH for the years 2004-2008 
indicate about 30,237 new invasive cancer cases and about 12,895 cancer deaths each year 
among Ohio males.4 Cancer of the prostate is the leading site/type for incidence (27% of new 
cases) while cancer of the lung and bronchus is the leading site/type for death from cancer 
(33% of cancer deaths). These data are presented in Tables 1 and 2. 
The OCISS and VS data for 2004-2008 also indicate about 29,085 new invasive cancer cases and 
about 12,027 cancer deaths each year among Ohio females.5 Breast cancer is the leading site/ 
type for the incidence cases (28%) while cancer of the lung and bronchus is the leading site/ 
type for cancer deaths (27%). These data are also presented in Tables 1 and 2. 
Regular cancer screening by health care professionals, can result in the detection 
of cancers of the breast, cervix, colon and rectum, skin, oral cavity and pharynx, 
prostate, and testis at early stages, when treatment is more likely to be successful.6 
The five-year relative survival probability for all screenable cancers combined is 
about 86%, and even higher for selected sites/types.6 
However, OCISS data for the years 2004-2008 indicate that about 29% of all 
female breast cancer cases and about 49% of all cervical cancer cases are 
diagnosed late (Regional or Distant) stage, when survival is poorest.5 About 
47% of colon and rectum cancers, 69% of lung and bronchus 
cancers, and 62% of oral cavity and pharynx cancers 
are diagnosed Regional or Distant stage. On a more 
positive note, about 86% of melanoma of the skin cases 
and about 83% of prostate cancer cases are diagnosed
in-situ or localized stage. These data indicate that 
Ohio needs to continue to increase awareness of the 
advantages of screening and early detection to reduce 
mortality from these cancers. These data are presented 
in Table 3. 
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Significant disparities exist in cancer incidence rates by race/ethnicity. As shown in Table 4, the 
2004-2008 average annual age-adjusted incidence rate for African Americans in Ohio (496.2 per 
100,000) is 7% higher than the rate for whites (465.2 per 100,000) and is more than double the 
rate for Asian/Pacific Islanders (241.4 per 100,000). The incidence rate for prostate cancer is 63% 
higher among African American males (216.5 per 100,000) compared to white males (132.5 per 
100,000), and the incidence rate of multiple myeloma is more than twice as high among African 
Americans (10.6 per 100,000) compared to both whites and Asian Pacific Islanders. Whites have 
a disproportionate burden of melanoma of the skin, with a 2004-2008 incidence rate (19.9 per 
100,000) that is 17 times higher compared to African Americans (1.2 per 100,000). Asian/Pacific 
Islanders in Ohio had lower incidence rates than other races for most cancer sites/types, with 
the exception of liver and intrahepatic bile duct cancer and stomach cancer. 
Table 5 presents the average annual number of cancer deaths and age-adjusted mortality 
rates for selected sites/types of cancer by race in Ohio for the years 2004-2008.7 These data 
indicate that African-American Ohioans have higher death rates for most cancer sites/types 
when compared to white and Asian/Pacific Islander Ohioans. The average annual mortality rate 
per 100,000 for all sites/types of cancer combined for African-Americans is 245.9 per 100,000 
which is 27% higher than the rate of 194.0 per 100,000 for whites. The disparity for prostate 
cancer mortality is very striking – the African-American male mortality rate is 52.4 per 100,000 
which is 121% higher than rate of 23.7 for white Ohio males. The reasons for these disparities 
are not clear but are likely multifactorial including access to screening and care, prevalence of 
risk factors, and the biology 
of the tumors. These data 
clearly indicate that Ohio 
needs to continue to work 
to address these issues and 
eliminate these disparities. 
 
      
      
      
Table 1. Average Annual Number and Percentage of New Invasive Cancer Cases and Age-Adjusted 
Incidence Rates per 100,000, by Cancer Site/Type and Gender in Ohio, 2004-20081,2 
Primary Cancer Site/Type 
Males Females Total 
Cases Percent Rate Cases Percent Rate Cases Percent Rate 
All Cancer Sites/Types 30,237 100.0% 552.7 29,085 100.0% 423.1 59,321 100.0% 474.6 
Brain and Other CNS** 451 1.5% 8.1 395 1.4% 6.1 845 1.4% 7.0 
Breast 70 0.2% 1.3 8,169 28.1% 120.3 8,239 13.9% 65.9 
Cervix * * * 483 1.7% 7.9 * * * 
Colon and Rectum 3,147 10.4% 58.5 3,162 10.9% 43.8 6,309 10.6% 50.1 
Esophagus 560 1.9% 10.2 149 0.5% 2.1 709 1.2% 5.6 
Hodgkin’s Lymphoma 185 0.6% 3.3 162 0.6% 2.7 348 0.6% 3.0 
Kidney and Renal Pelvis 1,153 3.8% 20.5 810 2.8% 11.8 1,963 3.3% 15.7 
Larynx 435 1.4% 7.6 128 0.4% 1.9 562 0.9% 4.4 
Leukemia 771 2.5% 14.4 622 2.1% 9.0 1,393 2.3% 11.3 
Liver and Intrahepatic Bile Duct 422 1.4% 7.4 182 0.6% 2.5 604 1.0% 4.7 
Lung and Bronchus 5,164 17.1% 95.5 4,229 14.5% 60.3 9,393 15.8% 75.0 
Melanoma of the Skin 1,251 4.1% 22.7 1,078 3.7% 17.0 2,329 3.9% 19.1 
Multiple Myeloma 359 1.2% 6.6 309 1.1% 4.3 668 1.1% 5.3 
Non-Hodgkin’s Lymphoma 1,270 4.2% 23.3 1,135 3.9% 16.3 2,405 4.1% 19.3 
Oral Cavity and Pharynx 875 2.9% 15.1 407 1.4% 5.9 1,282 2.2% 10.1 
Ovary * * * 831 2.9% 12.1 * * * 
Pancreas 737 2.4% 13.5 737 2.5% 10.1 1,474 2.5% 11.7 
Prostate 8,159 27.0% 146.7 * * * * * * 
Stomach 472 1.6% 8.8 297 1.0% 4.1 769 1.3% 6.1 
Testis 309 1.0% 5.7 * * * * * * 
Thyroid 274 0.9% 4.8 908 3.1% 14.9 1,182 2.0% 10.0 
Urinary Bladder 2,049 6.8% 39 700 2.4% 9.6 2,749 4.6% 21.9 
Uterine Corpus and Uterine NOS*** * * * 1,889 6.5% 27.4 * * * 
Other Sites/Types 2,124 7.0% * 2,303 7.9% * 4427 7.5% * 
1 Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2011 
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Table 2. Average Annual Number and Percentage of Cancer Deaths and Age-Adjusted 
Mortality Rates per 100,000, by Cancer Site/Type and Gender in Ohio, 2004-20081,2 
Primary Cancer Site/Type 
Males Females Total 
Cases Percent Rate Cases Percent Rate Cases Percent Rate 
All Cancer Sites/Types 12,895 100.0% 245.6 12,027 100.0% 165.9 24,922 100.0% 197.5 
Brain and Other CNS** 301 2.3% 5.4 250 2.1% 3.7 551 2.2% 4.5 
Breast 12 0.1% 0.2 1,859 15.5% 26.0 1871 7.5% 14.8 
Cervix * * * 163 1.4% 2.5 * * * 
Colon and Rectum 1,199 9.3% 23.1 1209 10.1% 16.0 2,408 9.7% 19.0 
Esophagus 524 4.1% 9.6 137 1.1% 1.9 662 2.7% 5.2 
Hodgkin’s Lymphoma 32 0.2% 0.6 25 0.2% 0.4 57 0.2% 0.5 
Kidney and Renal Pelvis 349 2.7% 6.6 227 1.9% 3.1 577 2.3% 4.6 
Larynx 141 1.1% 2.5 38 0.3% 0.6 180 0.7% 1.4 
Leukemia 514 4.0% 10.0 425 3.5% 5.8 939 3.8% 7.5 
Liver and Intrahepatic Bile Duct 380 2.9% 6.8 206 1.7% 2.8 586 2.3% 4.6 
Lung and Bronchus 4,195 32.5% 78.7 3209 26.7% 45.1 7,404 29.7% 59.1 
Melanoma of the Skin 213 1.7% 4.0 120 1.0% 1.7 333 1.3% 2.7 
Multiple Myeloma 242 1.9% 4.6 233 1.9% 3.1 476 1.9% 3.8 
Non-Hodgkin’s Lymphoma 487 3.8% 9.4 421 3.5% 5.6 908 3.6% 7.2 
Oral Cavity and Pharynx 228 1.8% 4.1 111 0.9% 1.5 340 1.4% 2.7 
Ovary * * * 589 4.9% 8.3 * * * 
Pancreas 705 5.5% 13.1 719 6.0% 9.7 1,424 5.7% 11.2 
Prostate 1,233 9.6% 25.8 * * * * * * 
Stomach 249 1.9% 4.8 173 1.4% 2.3 422 1.7% 3.4 
Testis 12 0.1% 0.2 * * * * * * 
Thyroid 30 0.2% 0.6 34 0.3% 0.5 65 0.3% 0.5 
Urinary Bladder 447 3.5% 9.0 189 1.6% 2.4 636 2.6% 5.0 
Uterine Corpus and Uterine NOS*** * * * 338 2.8% 4.6 * * * 
Other Sites/Types 1,399 10.9% * 1,349 11.2% * 2,749 11.0% * 
1 Source: Ohio Vital Statistics Program, Ohio Department of Health, 2011 




Table 2. Average Annual Number and Percentage of Cancer Deaths and Age-Adjusted
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Table 3. Average Annual Number and Percentage of New Cancer Cases 
by Stage at Diagnosis for Selected Sites/Types in Ohio, 2004-20081 
Primary Cancer Site/Type 




Cases Percent Cases Percent Cases Percent Cases Percent Cases Percent Cases 
Breast (Female) 1,871 19% 4,900 49% 2,501 25% 444 4% 324 3% 10,040 
Cervix * * 215 45% 182 38% 53 11% 33 7% 483 
Colon and Rectum 436 6% 2,507 37% 2,035 30% 1,116 17% 651 10% 6,745 
Lung and Bronchus 9 <1% 1,587 17% 2,250 24% 4,277 45% 1,279 14% 9,402 
Melanoma of the Skin 1,323 36% 1,819 50% 219 6% 91 2% 200 5% 3,652 
Oral Cavity and Pharynx 24 2% 371 28% 578 44% 235 18% 98 8% 1,306 
Prostate 3 <1% 6,770 83% 622 8% 275 3% 492 6% 8,161 
Testis 1 <1% 202 65% 63 20% 35 11% 9 3% 310 
1 Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2011
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Table 4. Average Annual Number and Percentage of New Invasive Cancer Cases and 
Age-Adjusted Incidence Rates per 100,000, by Cancer Site/Type and Race in Ohio, 2004-20081,2 
Primary Cancer Site/Type 
White African American Asian/Pacific Islander 
Cases Percent Rate Cases Percent Rate Cases Percent Rate 
All Cancer Sites/Types 51,982 100.0% 465.2 5,785 100.0% 496.2 292 100.0% 241.4 
Brain and Other CNS** 782 1.5% 7.4 51 0.9% 4.0 6 2.0% 5.4 
Breast (Female) 7,169 28.0% 119.1 830 29.6% 121.4 47 16.1% 37.5 
Cervix 411 1.6% 7.8 60 2.1% 8.6 4 1.4% 3.6 
Colon and Rectum 5,538 10.7% 48.9 630 10.9% 55.1 35 12.1% 35.6 
Esophagus 638 1.2% 5.6 62 1.1% 5.5 2 0.8% 2.9 
Hodgkin’s Lymphoma 300 0.6% 3.0 37 0.6% 2.8 2 0.6% 1.6 
Kidney and Renal Pelvis 1,733 3.3% 15.5 208 3.6% 17.4 7 2.3% 7.0 
Larynx 490 0.9% 4.3 66 1.1% 5.6 <1 0.3% **** 
Leukemia 1,251 2.4% 11.5 117 2.0% 9.7 10 3.3% 8.8 
Liver and Intrahepatic Bile Duct 477 0.9% 4.2 109 1.9% 8.9 12 4.2% 14.0 
Lung and Bronchus 8,325 16.0% 74.0 983 17.0% 86.7 35 11.8% 39.4 
Melanoma of the Skin 2,154 4.1% 19.9 14 0.2% 1.2 2 0.8% 3.4 
Multiple Myeloma 537 1.0% 4.7 122 2.1% 10.6 4 1.2% 4.8 
Non-Hodgkin’s Lymphoma 2,184 4.2% 19.6 158 2.7% 13.0 12 4.1% 12.5 
Oral Cavity and Pharynx 1,141 2.2% 10.1 118 2.0% 9.7 7 2.3% 7.2 
Ovary 757 3.0% 12.5 60 2.1% 8.8 5 1.7% 5.1 
Pancreas 1,282 2.5% 11.3 176 3.0% 15.5 7 2.5% 9.2 
Prostate 6,673 25.3% 132.5 1,037 34.8% 216.5 27 9.3% 27.9 
Stomach 629 1.2% 5.6 117 2.0% 10.4 11 3.7% 11.8 
Testis 289 1.1% 6.2 10 0.3% 1.6 2 0.7% 1.6 
Thyroid 1,047 2.0% 10.1 88 1.5% 7.0 12 4.2% 8.8 
Urinary Bladder 2,517 4.8% 22.2 137 2.4% 12.4 10 3.6% 12.6 
Uterine Corpus and Uterine NOS*** 1,710 6.7% 28.0 139 4.9% 20.6 10 3.4% 8.4 
Other Sites/Types 3,892 7.5% * 448 7.8% * 23 7.7% * 
1 Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2011 




****Rate not calculated when the 2004-2008 count is less than five (i.e., the average annual count is less than one). 
Note: Rates are gender-specific for breast, cervix, ovary, prostate, testis and uterine corpus/uterine NOS cancer. 
Table 4. Average Annual Number and Percentage of New Invasive Cancer Cases and 
Age-Adjusted Incidence Rates per 100,000, by Cancer Site/Type and Race in Ohio, 2004-20081,2
1 Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2011




****Rate not calculated when the 2004-2008 count is less than five (i.e., the average annual count is less than one).
Note: Rates are gender-specific for breast, cervix, ovary, prostate, testis and uterine corpus/uterine NOS cancer.
 
 
      
      
      
     
    
         
         
         
 
Table 5. Average Annual Number and Percentage of Cancer Deaths and Age-Adjusted 
Mortality Rates per 100,000, by Cancer Site/Type and Race in Ohio, 2004-20081,2 
Primary Cancer Site/Type 
White African American Asian/Pacific Islander 
Cases Percent Rate Cases Percent Rate Cases Percent Rate 
All Cancer Sites/Types 22,062 100.0% 194.0 2,756 100.0% 245.9 91 100.0% 85.5 
Brain and Other CNS** 518 2.3% 4.7 30 1.1% 2.5 3 3.1% 1.7 
Breast (Female) 1,624 7.4% 14.2 238 8.7% 20.5 4 8.8% 12.1 
Cervix 138 0.6% 2.4 23 0.8% 3.4 1 1.3% 1.4 
Colon and Rectum 2,122 9.6% 18.5 277 10.1% 25.2 8 8.4% 6.7 
Esophagus 603 2.7% 5.3 57 2.1% 5.0 2 2.2% 1.7 
Hodgkin’s Lymphoma 52 0.2% 0.5 5 0.2% 0.4 0 0.0% **** 
Kidney and Renal Pelvis 517 2.3% 4.5 57 2.1% 5.1 2 2.2% 1.8 
Larynx 152 0.7% 1.3 27 1.0% 2.4 0 0.0% **** 
Leukemia 854 3.9% 7.6 82 3.0% 7.3 3 3.7% 2.5 
Liver and Intrahepatic Bile Duct 486 2.2% 4.2 93 3.4% 7.8 7 7.9% 6.8 
Lung and Bronchus 6,586 29.9% 58.3 794 28.8% 70.9 18 20.3% 18.4 
Melanoma of the Skin 328 1.5% 2.9 4 0.2% 0.4 <1 0.2% **** 
Multiple Myeloma 394 1.8% 3.4 80 2.9% 7.3 1 1.1% 0.8 
Non-Hodgkin’s Lymphoma 850 3.9% 7.5 54 2.0% 4.7 4 4.2% 4.3 
Oral Cavity and Pharynx 294 1.3% 2.6 43 1.6% 3.7 2 2.6% 2.0 
Ovary 541 2.5% 8.5 46 1.7% 6.9 1 2.2% 3.5 
Pancreas 1,247 5.7% 10.9 170 6.2% 15.2 6 7.0% 6.5 
Prostate 1,029 4.7% 23.7 202 7.3% 52.4 2 2.2% 5.9 
Stomach 334 1.5% 2.9 82 3.0% 7.5 7 7.3% 6.3 
Testis 11 0.1% 0.2 1 0.0% 0.2 0 0.0% **** 
Thyroid 57 0.3% 0.5 7 0.2% 0.6 <1 0.4% **** 
Urinary Bladder 587 2.7% 5.1 47 1.7% 4.4 2 2.0% 2.2 
Uterine Corpus and Uterine NOS*** 286 1.3% 4.4 50 1.8% 7.6 2 1.8% 3.1 
Other Sites/Types 2,453 11.1% * 286 10.4% * 10 10.6% * 
1 Source: Ohio Vital Statistics Program, Ohio Department of Health, 2011
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CANCER DATA AND SURVEILLANCE 
Background: 
Cancer surveillance is the systematic collection and analysis of data that is used to guide the 
development, implementation, and evaluation of cancer prevention and control initiatives in Ohio. 
By collecting and analyzing data on cancer incidence and mortality, cancer surveillance provides 
stakeholders with a better understanding of cancer and appropriate strategies and policies for 
cancer prevention, treatment, and control. The availability of statewide cancer data enables 
health researchers and policy makers to analyze demographic and geographic factors that impact 
cancer risk, early detection, and effective treatment of cancer patients. Combined with behavioral, 
attitudinal, environmental, and structural data, cancer surveillance informs the development, 











GOAL 1: Enhance the Quality and Reporting of Cancer Incidence Data and Increase
the Dissemination and Use of Data for Cancer Prevention and Control. 
Objective 1.1: By December 31, 2014, identify and provide data and information 
relevant to the 10 objectives/activities in the Ohio Comprehensive Cancer 
Prevention and Control Plan 2011-2014 for planning, monitoring and evaluation. 
Measure: Baseline = 0, December 31, 2014 Target = 10 
Data Source(s): 
•	 Ohio Cancer Incidence Surveillance System (OCISS) 
•	 Ohio Vital Statistics (VS) 
•	 Ohio and U.S. Behavioral Risk Factor Surveillance System (BRFSS) 
•	 Youth Risk Behavior Survey (YRBS) 
•	 Adult Tobacco Survey (ATS) 
•	 Youth Tobacco Survey (YTS) 
•	 Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute 
•	 National Center for Health Statistics 
Time Frame: No later than December 31, 2014 
Responsible Parties/Partners: 
•	 Ohio Department of Health (ODH) Chronic Disease and Behavioral Epidemiology 
(CDBE) Section 
•	 OCISS 
•	 ODH Center for Public Health Statistics and Informatics (CPHSI) 
•	 Ohio VS Program 
•	 The Ohio State University 
•	 ODH Comprehensive Cancer Control Program (OCCCP).
Strategy 1.1.1: Participate in meetings with other OPCC committees to identify data 
sources for planning, monitoring and evaluating OPCC objectives and activities 
Strategy 1.1.2: Collect and/or analyze relevant data and provide to OPCC committee 
members 
Strategy 1.1.3: Assist with the development of status/evaluation reports to track progress 










Objective 1.2: Achieve at least 90 percent completeness of case reporting to the 
OCISS at 12 months based on the National Program of Cancer Registries (NPCR) 
evaluation method no later than December 14, 2014. 




•	 OCISS Gateway 
•	 CRS Plus 
•	 OCISS staff 
•	 Epidemiology staff 
•	 OCISS reporting facilities 
•	 State funding 
•	 Federal funding 
Time Frame: No later than December 31, 2014 
Responsible Parties/Partners:
•	 OCISS staff 
•	 Reporting facilities 
•	 OCISS Data Quality Improvement Committee 
•	 OPCC Data and Surveillance Committee 
•	 OPCC Communications Committee 
•	 ODH CDBE Section 
•	 The Ohio State University 
Strategy 1.2.1: Conduct an assessment of non-reporting facilities (e.g. dermatology, urology,
free-standing surgery) to identify reasons for non-compliance and target interventions
accordingly. 
Strategy 1.2.2: Identify and contact new and/or prospective reporting sources to assure 
compliance with reporting laws 
Strategy 1.2.3: Develop and distribute educational materials on the importance of and how 
to properly collect and report required data elements 
Strategy 1.2.4: Establish list-serves of reporting sources for dissemination of OCISS reports to 
educate on the reporting sources on how the OCISS data are being used 
Strategy 1.2.5: Conduct an assessment of factors associated with lower case completeness, 
overall and by site/type (e.g., impact of Ohio cancer mortality rates, differences in 
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Objective 1.3: Create and disseminate three comprehensive cancer reports, e.g. “stage 
at diagnosis”, “cancer facts and figures”, “community cancer profiles” no later than 
December 31, 2014 for cancer prevention and control education, program planning and 
policy development. 







•	 OCISS data 
•	 VS mortality data 
•	 BRFSS data 
•	 SAS and SEER*Stat analytic software 
•	 ODH CDBE Section 
•	 The Ohio State University 
•	 OCCCP 
•	 American Cancer Society East Central Division. 
Time Frame: No later than December 31, 2014 
Responsible Parties/Partners: 
•	 ODH CDBE Section 
•	 The Ohio State University 
•	 OCCCP 
•	 American Cancer Society East Central Division 
•	 OPCC Data and Surveillance Committee. 
Strategy 1.3.1: Participate in quarterly meetings/conference calls with responsible parties/partners 
Strategy 1.3.2: Develop a timeline for data analysis, generation of tables/figures, drafting text, 
document review, completion, printing and distribution 
Strategy 1.3.3: Develop a plan for distribution to target audience(s) 
Strategy 1.3.4: Analyze data by relevant demographic (e.g., age, race/ethnicity, sex) and geographic 
(e.g., Appalachia, county, urban/rural) breakdowns to identify populations to target for cancer 
prevention, early detection and control initiatives 
Strategy 1.3.5: Analyze trends in cancer incidence, mortality and stage at diagnosis to monitor 











Objective 1.4: Disseminate three cancer-related datasets through the new Ohio Public 
Health Information Warehouse for use by health professionals and the general public 
no later than December 31, 2014. 






•	 OCISS data 
•	 VS mortality data 
•	 BRFSS data 
•	 ODH Office of Management Information Systems (OMIS) 
•	 Ohio Public Health Information Warehouse (the Warehouse) Committee 
•	 Server and network capacity 
•	 State funding 
•	 Federal funding 
Timeline: No later than December 31, 2014 
Responsible Parties/Partners:
•	 ODH CDBE Section 
•	 OCISS 
•	 ODH CPHSI 
•	 ODH OMIS 
•	 City and county health departments 
Strategy 1.4.1: Participate in scheduled meetings to determine cancer-related data and 
variables to be included in the Warehouse, with an emphasis on identifying disparate 
populations 
Strategy 1.4.2: Assist with development of tabular, graphical, and mapping functionality for 
presentation of cancer-related data 
Strategy 1.4.3: Conduct user acceptance testing prior to release of cancer-related data in the 
Warehouse 
Strategy 1.4.4: Develop descriptive text, frequently asked questions, and technical notes 
regarding collection, analysis, and presentation of cancer-related data 
 
Strategy 1.4.5: Develop a communication plan to optimize use of the Warehouse by health 
professionals and the public (e.g. encourage use of RSS feeds, promote the Warehouse to city 











Objective 1.5: By December 31, 2014 Increase the Number of City and County 
Health Departments Who are Able to Use Data for Cancer Prevention and Control, 
and Community Assessments from 4 to 20. 
Measure: 2011 Baseline = 4 (Cuyahoga County, Summit County, Columbus City, Hamilton 






•	 OCISS data 
•	 VS mortality data 
•	 BRFSS data 
•	 The Warehouse 
•	 CDBE Section 
•	 The Ohio State University 
•	 Venue(s) for training funding 
•	 Funding 
Time Frame: No later than December 31, 2014 
Responsible Parties/Partners: 
•	 CDBE Section 
•	 OCISS 
•	 ODH CPHSI 
•	 The Ohio State University 
•	 City and county health departments 
Strategy 1.5.1: Revise the “Ohio Community Cancer Concerns Response Protocol” (the 
Response Protocol) 
Strategy 1.5.2: Update PowerPoint slides/materials on how to conduct community cancer 
assessments 
Strategy 1.5.3: Create media (e.g. toolkit, website, webinar) that includes links to data 
and information relevant to cancer prevention, control and community assessments (e.g. 
links to census and comparison data, copies of previous assessments, reports, statistical 
programs, and spreadsheets for calculating relevant statistics) 
Strategy 1.5.4: Promote new OCISS data release policies to city and county health 
department 
Strategy 1.5.5: Conduct a train-the-trainer session with city and county health 
departments on how to conduct a community cancer assessment (e.g. analysis and use 
of data for cancer prevention and control, use of the Response Protocol, responding to 
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PRIMARY PREVENTION 
Primary prevention of cancer consists of actions taken by individuals, communities, institutions, 
and governments to protect against the occurrence of cancer. This includes promotion of 
measures that reduce the risk of developing cancer by encouraging healthy lifestyles and 
environments and empowering Ohioans to make informed decisions. 
Adopting specific lifestyle behaviors can reduce cancer risk. The healthy lifestyle behaviors 
most effective on prevention cancer include avoiding tobacco products and exposure to 
secondhand smoke, minimizing alcohol intake, following a balanced diet, exercising 
regularly, and protecting against ultraviolet exposure. Other behaviors linked to cancer 
prevention include breastfeeding, practicing healthy sexual behaviors, and obtaining 
appropriate vaccinations. Raising awareness regarding the impact Ohioans can have on their 
own health through adopting healthy lifestyles is an important step toward cancer prevention. 
This chapter of the Plan will focus on prevention strategies pertaining to tobacco use, 
exercise and improved nutrition, and ultraviolet (UV) light exposure, radon, and the human 
papillomavirus. 
 
GOAL 2: Reduce Tobacco Use among Ohioans 
Background: 
Tobacco smoking causes about 30 percent of all U.S. deaths from cancer. Avoiding tobacco 
use is the most important step Ohioans can take to reduce the cancer burden in our state. 
Cigarette smoking is the leading preventable cause of death in the United States and Ohio. 
Tobacco smoking causes cancer of the lung, larynx, mouth, esophagus, pharynx, pancreas, 
kidney, cervix, and stomach, as well as acute myelogenous leukemia. According to the 2010 
BRFSS, 22.5 percent of adults in Ohio are current cigarette smokers. 
Due to funding reductions, the Ohio Tobacco Quit Line now only provides free cessation 
telephonic counseling services to uninsured, Medicaid recipients, pregnant women and 
members of the Ohio Tobacco Collaborative. The Ohio Tobacco Collaborative is a unique 
public-private partnership which provides insurance carriers, employers and third party 
administrators with access to Ohio Tobacco Quit Line services at a state-negotiated (reduced) 
rate. Funds for the quit line come from the Centers for Disease Control and Prevention and are 
available through March 28, 2012. 
In 2009, the ODH Tobacco Use Prevention and Cessation Program () established a strategic plan 
for sustaining the quit line. This plan included the establishment of the Ohio Tobacco Cessation 
Benefits Team (OH CBT) to engage public and private health insurers and employers to provide 
cessation benefits for the treatment of tobacco use dependence and to identify opportunities 
to increase sustainability for existing cessation services, including the Ohio Tobacco Quit Line. 
The partnership includes the Bureau of Healthy Ohio, The Ohio Departments of Job and Family 
Services, Health Action Council Ohio, Medical Mutual Insurance Company of Ohio, the Ohio 
Association of Health Plans, Cleveland Clinic, National Jewish Health, Center for Community 
Solutions, Kent State University, American Cancer Society, American Heart Association, 
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Objective 2.1: By December 31, 2014, 2.3 million Ohioans will have access to the 
Ohio Tobacco Quit Line because their employer or health plan joined the Tobacco 
Collaborative. 
Measure: 
August, 2011 Baseline = 2.1 million Ohioans 
December 31, 2014 Target = 2.3 million Ohioans 
Data Source: National Jewish Health tracks the “covered lives” of employers and health plans 
that sign partnership agreements with the Ohio Tobacco Collaborative 
Time Frame: No later than December 31, 2014 
Responsible Parties/Partners: 
•	 Tobacco Use Prevention and Cessation Program National Jewish Health 
•	 Local health departments 
•	 Tobacco Control advocates 
Strategy 1.1.1: Ensure Ohioans have access to quit line services 
Strategy 1.1.2: Promote tangible solutions to provide cessation benefits that are cost 
effective, evidence-based and use the combined leverage of public and private sectors 
Strategy 1.1.3: Promote the Tobacco Collaborative and the Ohio Cessation Benefits Team 
Objective 2.2: By June 30, 2014, Ensure all Medicaid clients have access to 
cessation services. 
Measure: August 2011 Baseline=120,000; June 30, 2014 Target = all Medicaid clients 
Data Source: TUPCP, Ohio Department of Job and Family Services (ODJFS), Medicaid 
Time Frame: No Later than June 30, 2014 
Strategy 2.2.1: ODH will work with the Ohio Department of Job and Family Services 
Medicaid to discuss changes to Ohio Administrative Code to allow the Ohio Medicaid 
Benefit Plan to pay for quit line calls and tobacco use cessation counseling for all clients 
Strategy 2.2.2: ODH will work with partners to ensure all Medicaid clients have access to 
cessation services 
Key Partners: 
•	 Ohio Department of Job and Family Services -Ohio Medicaid 
•	 ODH Tobacco Use Prevention and Cessation Program 
•	 Centers for Disease Control and Prevention 
GOAL 3: Reduce Exposure to Environmental Carcinogens 
Background: 
Naturally occurring as well as man-made exposures to environmental 
contaminants have been proven to increase the risk of cancer. Secondhand 
smoke (also known as environmental tobacco smoke) and indoor radon 
(formed by the breakdown of radium in soil and rock) continue to be leading 
environmental hazards. 
It has been repeatedly demonstrated that comprehensive tobacco free school 
policies, combined with other efforts are effective in reducing the prevalence of 
tobacco use among youths. 
The majority of Ohio homeowners are not aware of their risk of having elevated 
levels of radon in their homes or the cancer risk associated with exposure to 
radon. While current data indicates that Ohio homeowners are at considerable 
risk for elevated levels of indoor radon, only about 6% of all Ohio homes have 
been tested and even fewer homes have had radon mitigation systems installed. 
It is clear that increased efforts to educate homeowners about home testing of 
















Objective 3.1: By March 28, 2014, increase the number of Ohio school districts 
with 100% tobacco-free policies at all facilities, at all events on school property and 
at all school sponsored events at all times from 173 to 261. 
Measure: August 2011 Baseline of 173 school districts; March 28, 2014 Target of at least 261 
school districts 
Data Source: TUPCP maintains a database of school districts across Ohio and the 
corresponding tobacco policies 
Time Frame: No later than March 28, 2014 
Responsible Parties/Partners 
•	 Tobacco Free Ohio Alliance 
•	 Educated Service Centers 
•	 Ohio Tobacco Use Prevention and Cessation Program 
•	 Local Health Departments 
•	 Ohio Department of Education 
•	 American Heart Association 
Strategy 3.1.1: Provide funding to local health departments and non-profit agencies to 
promote tobacco free school policies 
Strategy 3.1.2: Work with the Ohio Educational Service Center Association to promote a 
tobacco free school policy 
Strategy 3.1.3: Work to secure approval and support from the State Board of Education 
Objective 3.2: By December 31, 2014, increase the number of Ohio multi-unit 
housing complexes with 100% tobacco-free policies from 0 to 5. 
Measure:
•	 August 2011 Baseline of 0; March 28, 2014 Target of at least 5 multi-unit housing 
complexes 
Data Source: TUPCP will create a database to track units as they change 
Time Frame: No later than March 28, 2014. 
Responsible Parties/Partners 
•	 Tobacco Free Ohio Alliance 
•	 Ohio Tobacco Use Prevention and Cessation Program 
•	 Local Health Departments 
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Strategy 3.2.1: Provide funding to local health departments and non-profit agencies to 
promote tobacco free multi-unit housing strategies 
Strategy 3.2.2: Provide resources and information to landlords and tenants about smoke 
free multi-unit housing 
Objective 3.3: By December 31, 2014, Increase the Percentage of Ohio Homes that 
Have Been Tested to Determine Indoor Radon Level From 6% to 7%. 
Measure: 
•	 September 2011 Baseline of 6% of Homes; December 31, 2014 Target of at least 7% homes 
Data Source: University of Toledo, Ohio Radon Information System US Census 
Resources: U.S. EPA
 ODH Bureau of Radiation Protection
 ODH Indoor Radon Program
 Local Health Departments 
Time Frame: No later than December 31, 2014. 
Responsible Parties/Partners: 
•	 ODH Indoor Radon Program 
•	 Ohio Association of Radon Professionals 
•	 ODH Healthy Homes/Lead Prevention Program 
•	 ODH Comprehensive Cancer Control Program 
•	 Ohio Realtors Association 
•	 Community Development Program of the State of Ohio 
•	 U.S. Department of Agriculture Rural Development Program 
Strategy 3.3.1: Develop and implement continuing education courses and presentations 
specifically for realtors, builders, and the medical community 
Strategy 3.3.2: Increase awareness of indoor radon and the health risk associated with 
exposure to indoor radon by increasing the number of outreach and education activities 
by 10 each year. [2010 baseline=130 activities] 
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GOAL 4: Increase the Proportion of Adults and Children who 
 Engage in Recommended Physical Activity Levels. 
Background: 
Considerable evidence indicates that several lifestyle behaviors are known risk factors for 
many chronic diseases and conditions, including several forms of cancer. Unhealthy diets and 
physical inactivity, which are risk factors for overweight and obesity, may account for about 
25-30 percent of the cancer deaths in men and 20 percent of cancer deaths in women.8 
Overweight and obese children are at increased risk for cancer, especially because they are 
more likely to become overweight and obese as adults. Currently, about 1 in 3 children in the 
U.S. are overweight or obese, and fruit/vegetables consumption and physical activity levels 
are below recommended levels. Obesity disproportionately affects minorities. Therefore, it is 
imperative that efforts be made to improve the diets and physical activity levels of adults and 
children in order to reduce obesity and prevent cancer. 
Objective 4.1: By December 31, 2014 increase the proportion of Ohio adults age 
18 and older who engage in at least 30 minutes of moderate to vigorous physical 
activity 5 or more days of the week to at least 54%. 
Objective 4.2: By December 31, 2014, decrease the proportion of Ohio adults age 
18 and older who engaged in no leisure-time physical activity in the preceding 
month to at least 23%. 
Measures: 
• 2009 baseline of adults who engage in moderate or vigorous activity is 49%;
December 31, 2014 Target is increase to at least 54%
• 2009 baseline of adults not engaging in any leisure time physical activity is 26%;
December 31, 2014 Target is decrease to at least 23%
Data Source: Ohio BRFSS 
Time Frame: No later than December 31, 2014 
Responsible Parties/Partners: 
• ODH Office of Healthy Ohio
• Worksite Wellness Programs
• Fitness/Health Clubs
• Ohio Parks and Recreation
• Ohio Department of Transportation
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Strategy 4.2.1: Support worksite programs to promote physical activity 
Strategy 4.2.2: Support physical activity and healthy eating programs, specifically for African 
American and Latino populations 
Strategy 4.2.3: Support the increased availability of safe and accessible recreational facilities 
in the community, as well as the development and operation of community-based recreation 
centers for all people, including the elderly and disabled 
Strategy 4.2.4: Support community-wide campaigns to promote physical activity 
Strategy 4.2.5: Encourage mixed-use zoning with homes situated within walking and bicycle-
riding distance of attraction, walker-friendly commercial, business, and community facilities 
Objective 4.3: By December 31, 2014, increase the proportion of children in grades 
9-12 who engage in physical activity for a total of at least 60 minutes per day 7 days of 
the week to at least 30%. 
Measure: 2010 Baseline=25%; December 31, 2014 = 30% 
Data Source: Ohio YRBS grades 9-12, Ohio School Health Profiles 
Time Frame: No later than December 31, 2014 
Responsible Parties/Partners: 
•	 ODH Bureau of Healthy Ohio 
•	 ODH Coordinated School Health Manager 
•	 Ohio Department of Education 
•	 Ohio Parks and Recreation 
•	 Ohio Department of Transportation 
•	 Ohio Department of Development (city planners) 
Strategy 4.3.1: Support initiatives that increase the proportion of school districts that provide 
30 minutes of physical activity per day 
Strategy 4.3.2: Develop a position statement on the importance of physical activity and 
physical education in schools related to chronic disease prevention and academic success 
Strategy 4.3.3: Support initiatives that increase the availability of safe and accessible 





Strategy 4.3.4: Increase the portion of physical education teachers who receive professional 
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GOAL 5: Increase the Proportion of Adults and Children  
 Who Engage in Healthy Eating Behaviors 
Objective 5.1: By December 31, 2014 increase the proportion of adults aged 18 and over 
who consume fruits and vegetables five or more times per day to at least 26%. 
Measure: 2009 Baseline=21%; December 31, 2014 Target= at least 26% 
Data Source: Ohio BRFSS 
Time Frame: No later than December 31, 2014 
Responsible Parties/Partners: 
• ODH Bureau of Healthy Ohio
• Fitness/Health Clubs
• Worksite Wellness Programs
• ODH Comprehensive Cancer Control Program
Strategy 5.1.1: Support the development and funding of community-wide programs to
promote healthy eating, including the daily consumption of 5 or more servings of fruits
and vegetables, especially among minorities and populations at high risk
Strategy 5.1.2: Support worksite programs to promote healthy eating, including
promoting the daily consumption of 5 or more servings of fruits and vegetables
Strategy 5.1.3: Support worksite policies that require appealing, high quality and
affordable healthy foods, especially fruits and vegetables at cafeterias, vending machine,
and other worksite dining options
Strategy 5.1.4: Support worksite policies for breastfeeding mothers per Federal regulation
Strategy 5.1.5: Support improved access to fruits and vegetables by promoting corner
stores, community gardens and farmers’ markets, such as those established through CDC’s
Creating Healthy Communities program
Strategy 5.1.6: Support the development of social marketing campaigns to promote
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 Objective 5.2: By December 31, 2014 increase the proportion of children in grades 
9-12 who ate fruits two or more times per day and ate vegetables three or more 
times per day during the past seven days to at least 12 percent. 
Measure: 2011 Baseline= 7 percent; December 31, 2014 Target = 12 percent 
Data Source: Ohio YRBS (grades 9-12) 
Time Frame: No later than December 31, 2014 
Responsible Parties/Partners: 
• ODH Bureau of Healthy Ohio
• Ohio Department of Education
• ODH Coordinated School Health Manager
• ODH Comprehensive Cancer Control Program
Strategy 5.2.1: Support community initiatives to promote healthy eating behaviors,
including the daily consumption of 5 or more servings of fruits and vegetables, by
increasing access through corner stores, farmers markets and community partners
Strategy 5.2.2: Support school-based campaigns to promote healthy, low-fat eating,
including promoting the daily consumption of 5 or more servings of fruits and vegetables
Strategy 5.2.3: Support school policies requiring that a variety of healthy choices be
provided in vending machines, school stores, and other venues within the schools control
Strategy 5.2.4: Support initiatives that increase the number of districts with model
wellness policies that include specific guidance for all food and beverages sold at school,







ontrol Plan 2011-2014  | 36 
GOAL 6: Increase the Vaccination Rate for Vaccines Shown to Reduce the 
  Risk of Cancer. 
Objective 6.1: At least 60% of girl’s age 13-17 years will have received at least one 
dose of Human Papillomavirus vaccine by December 31, 2014. 
Supporting data: 
• The 2010 National Immunization Survey baseline for girl’s age 13-17 years is 44.0%
Objective 6.2: At least 50% of girl’s age 13-17 years will have received three doses 
of Human Papillomavirus vaccine by December 31, 2014. 
Supporting data: 
• The 2010 National Immunization Survey baseline for girls 13-17 years is 31.1%
Objective 6.3: Within three days after birth at least 95% of newborns will receive 
one birth dose of Hepatitis B vaccine by December 31, 2014. 
Supporting data: 
• The 2010 National Immunization Survey baseline is 73.5% within three days.
Objective 6.4: At least 95% of infants 19-35 months will receive three doses of 
hepatitis B vaccine by December 31, 2014. 
Supporting data: 
• The 2010 National Immunization Survey baseline is 94.8%.
Strategy 6.1.1: Raise awareness of human Papillomavirus (HPV) vaccine through a multi­
media approach
Strategy 6.1.2: Increase provider participation and improve completion of vaccination
protocols in Ohio’s statewide immunization information system (Advisory Committee for
Immunization Practices)
Strategy 6.1.3: Promote the universal hepatitis B birth dose program and the importance
of hepatitis B vaccine
Responsible Parties/Partners: 
• Office of Immunization Program, Ohio Department of Health
• Reproductive Health and Wellness Program, Ohio Department of Health








GOAL 7: Reduce Exposure to Ultraviolet Radiation from the Sun and Sun Lamps. 
Background: 
Skin cancer is the most commonly diagnosed cancer in the United States, with over 1 million 
cases of non-melanoma diagnosed each year. Scientific studies have shown the relationship 
between sun exposure and skin cancer and have credited sun exposure as the cause of over 
90% of all non-melanoma skin cancers.9 




Source: BRFSS 2004 

Baseline: 33.7% 2014 Goal: 30%
 
Strategy 7.1.1: Increase the proportion of adults aged 18 and older who follow protective 
measures that may reduce the risk of skin cancer via church-based and local business-
based education programs 
Objective 7.2: Reduce the percentage of youth (ages 14-17) reporting sunburns in 
the past 12 months. Source: National Health Interview Survey, 2010 
Baseline: 33% 2014
Goal: 30% 
Strategy 7.2.1: Increase awareness among youth regarding the dangers of unprotected 
exposure to UV rays and the recommended practices for sun-protective behavior through 
sunscreen programs at local high schools 
Strategy 7.2.2: Conduct a school health assessment regarding policies on sun exposure 
on playgrounds, school sporting events, etc. 
Objective 7.3: Reduce the percentage of youth (grades 9-12) who have used a 




Strategy 7.3.1: Support initiatives that increase awareness among youth regarding the
dangers of indoor tanning beds through structured education programs in high schools
using sophisticated software designed to simulate the effects of sun damage at various ages 
Responsible Parties/Partners: 
• American Cancer Society
• OhioHealth Research Institute
• Center for Appalachia Research in Cancer Education
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SCREENING AND EARLY DETECTION
 
GOAL 8: Improve Screening and Early Detection and Follow-up for Breast,  
Colorectal, and Cervical Cancers. 
Introduction: 
The use of screening tests to detect cancers early provides better opportunities for patients to 
obtain more effective treatment with fewer side effects. Patients whose cancers are found early 
and treated in a timely manner are more likely to survive these cancers than are those whose 
cancers are not found until symptoms appear. Disparities remain for immigrants and those with 
lower incomes, with less education, without insurance, and lacking a usual health care provider. 
Breast Cancer: 
Regular use of screening mammograms, followed by timely treatment when breast cancer is 
diagnosed, can help reduce the chances of dying from breast cancer. For women between the 
ages of 50 and 69, there is strong evidence that screening lowers this risk by 30 percent. For 
women in their 40s, the risk can be reduced by about 17 percent.10 
Objective 8.1: By December 31, 2014, increase the proportion of women 

aged 40 years and older who have had a mammogram within the past 






Mammography is especially valuable as an early detection tool because 
it can identify breast cancer at an early stage, usually before physical 
symptoms develop. Numerous studies have shown that early detection 
saves lives and increases treatment options. According to Ohio Cancer 
Facts & Figures 20107, 68% of breast cancers are diagnosed at a localized 
stage, for which the five-year survival rate is 98%. According to the 
2010 Ohio Behavioral Risk Factor Surveillance Survey (BRFSS), 60% of 
Ohio women 40 and older reported having had a mammogram in the 
past year. Also according to the 2010 BRFSS, more African Americans 
(67%) than whites (59%) reported having had a mammogram in the past 
year. According to the 2010 Ohio BRFSS, the percentage of women without 
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Strategy 8.1.1: Advocate for increased funding for programs that support free and low 
cost mammography for women with no or limited health care insurance 
Strategy 8.1.2: Create strategic partnerships with state and local systems or networks to 
reach age-appropriate women who have never been screened for breast cancer 
Strategy 8.1.3: Improve age-appropriate screening among members of large health plans 
and employers to impact breast cancer screening 
Strategy 8.1.4: Enhance the ability of all healthcare providers to create office policies that 
ensure the recommendation of early detection screening focusing on women with no or 
limited health care insurance 
Responsible Parties/Partners: 
•	 Ohio Breast and Cervical Cancer Project 
•	 Ohio Breast and Cervical Cancer Coalition 
•	 American Cancer Society 
•	 Commission on Cancer 
•	 Susan G. Komen for the Cure 
•	 OhioHealth Research Institute 
•	 Ohio Commission on Cancer 
•	 Center for Appalachia Research in Cancer Education 
•	 Healthcare Systems 
•	 Employers and Health Plans 
Colorectal Cancer:
Colorectal cancer is the third leading cause of cancer death in the US in men and women. 
Colorectal cancer screening can detect cancerous tumors and polyps, or abnormal cells 
growth which can develop into colorectal cancer. If colorectal cancer screening reveals a 
problem, diagnosis and treatment can occur promptly. In addition, finding and removing 
polyps or other areas of abnormal cell growth may be one of the most effective ways to 
prevent colorectal cancer development. Also, colorectal cancer is generally more treatable 
when it is found early, before it has had a chance to spread. 
Health care providers may suggest one or more tests for colorectal cancer screening, including 
a fecal occult blood test (FOBT); sigmoidoscopy; regular, or standard, colonoscopy; virtual 
colonoscopy; double contrast barium enema (DCBE); Fecal immunochemical test (FIT) or Stool 
DNA test. People should talk with their health care provider about when to begin screening 












Objective 8.2: By December 31, 2014, Increase the number of adults 50 years or 
older who receive colorectal cancer screening in accordance with American Cancer 
Society guidelines. Baseline (2010 Ohio BRFSS): 64%; Goal: 70% Supporting data: 
Colonoscopy and flexible sigmoidoscopy offer the best opportunity to detect colorectal cancer at 
an early stage, when successful treatment is likely, and to prevent some cancers by detection and 
removal of polyps. According to the 2010 BRFSS, 53% of Ohioans 50 and older reported having 
had a sigmoidoscopy or colonoscopy within the past five years. Ohio Cancer Facts & Figures 20107 
states that the relative five-year survival is 90% for colorectal cancer patients diagnosed at an early, 
localized stage; however, only 43% of cases are diagnosed at this stage. Colorectal cancer is one 
of the few cancers that can also be prevented through screening because precancerous polyps, 
from which these cancers usually develop, can be identified and removed. Of the 51,370 people 
expected to die of colorectal cancers in 2010 in the United States, early detection could save more 
than half. 
According to the 2008 National Health Interview Survey: 
•	 People with no health insurance coverage have significant access barriers and are less likely to 
be up-to-date with CRC screening compared to their insured counterparts.
•	 Between 2000 and 2008, there were significant increases in the use of CRC screening within 
recommended time intervals across race and ethnic groups of insured adults (aged 50 to 
64). The largest increases in CRC screening utilization occurred among insured non-Hispanic 
whites. 
•	 In 2008, the prevalence of colorectal cancer screening varied by race, education, health 
insurance coverage, and immigration status; those without health insurance, those with less 
than a high school education, Hispanics, and immigrants who had been in the US for fewer 
than 10 years were the least likely to have had a colorectal cancer screening test. 
Strategy 8.2.1: Advocate for increased funding for programs that support no-cost and low 
cost CRC screening 
Strategy 8.2.2: Develop sources for no-cost or low cost colorectal cancer screening for 
people without access to medical coverage 
Strategy 8.2.3: Create strategic partnerships with state and local systems or networks to 
reach age-appropriate individuals who should be screened for CRC with focus on groups that 
experience high mortality rates from CRC cancer 
Strategy 8.2.4: Improve utilization among large health plans and employers to impact CRC 
screening 
Strategy 8.2.5: Enhance the ability of all healthcare providers to create office policies that 
ensure the recommendation of early detection screening with focus on providers that work 
with groups that experience high mortality rates from CRC 
Strategy 8.2.6: Engage in community coalition building and development in priority 
communities to ensure a comprehensive community-based solution to increasing the early 













•	 Ohio Colorectal Cancer Coalition, Healthcare Systems 
•	 Employers 
•	 Health Plans 
Objective 8.3: The Ohio Academy of Family Physicians will develop and execute 
professional education initiatives to increase colorectal cancer screening no later 
than December 31, 2012. 
Supporting Data: 
•	 Consultation with colleagues at the American Cancer Society (ACS) East Central Division 
and a review of recent peer-reviewed published papers regarding CRC reveals that barriers 
to physician referrals for screening include, but are not limited to: (a) outdated knowledge; 
(b) inconsistently followed guidelines; and, (c) inadequate resources and reinforcement.
•	 To address this critical issue the Comprehensive Cancer Control Program at the Ohio 
Department of Health has entered into a contract with the Ohio Academy of Family 
Physicians (OAFP) for an initiative to increase colorectal cancer screening. This contract will 
fund the development of professional education services for family physician practices 
which will be effective in assisting those practices in improving their colonoscopy referred 
patterns and systems.
Strategy 8.3.1: This evidence-based intervention will focus on OAFP members using 
the professional education materials developed by the Thomas Jefferson University, 
Department of Family Medicine in collaboration with the American Cancer Society national 
office: How to Increase Colorectal Cancer Screening Rates in Practices: A Primary Care Clinician’s 
Evidence-Based Tool Kit and Guide. These professional education materials include three 
evidence-based strategies to increase CRC screening rates: (1) Office policies; (2) Reminder 
Systems; and, (3) communication. Other activities will include: (4) Establishing a baseline 
colorectal cancer screening rate for the practice; and, (5) tracking the completion of 
colorectal cancer screening to detect if an increase in screening is taking place as a result of 
the professional education intervention. 
Responsible Parties/Partners 
•	 Ohio Academy of Family Physicians (OAFP) 
•	 American Cancer Society (ACS) East Central Division 












Objective 8.4: Promote cervical cancer screening following nationally recognized 
guidelines. 
Objective 8.5: Ensure appropriate follow-up for women who receive abnormal Pap 
smear results. 
Objective 8.6: Reduce financial barriers to cervical cancer screening and follow-up 
testing (i.e., colposcopy). 
Supporting data: 
The OCISS incidence data for the years 2004-2008 indicate about 483 new cases of invasive 
cervical cancer among Ohio females.5 About 49% of these cervical cancers are diagnosed late 
(Regional, Distant) stage, when survival is poorest.5 The 2004-2008 data indicate about 165 
cervical cancer deaths among Ohio females each year.5 
Significant disparities exist in the cervical cancer incidence and mortality rates by race and 
ethnicity. The average annual age-adjusted incidence rate per 100,000 for Ohio African 
American females is 8.6 which is about 10% higher than the white female rate of 7.8 and about 
138% higher than the rate of 3.6 for Asian/Pacific Islander females.5 The average annual age-
adjusted cervical cancer death rate per 100,000 is 3.4 for African American females which is 
42% higher than the white female death rate of 2.4 and 143% higher than the death rate of 1.4 
for Asian/Pacific Islander females.5 
The U.S. Preventive Services Task Force (USPSTF) recommends that women aged 21-65 with a 
cervix be screened for cervical cancer and precancerous lesions by Papanicolaou (Pap) smear 
every three years.11 The 2010 Ohio Behavioral Risk Factor Survey data for Ohio women aged 
18 years and older indicates that about 82% of white women and about 88% of Black women 
have had a Pap test in the past three years.12 The Healthy People 2020 target is 93.0%.13 
These data indicate that invasive cervical cancer remains a significant source of morbidity and 
mortality for Ohio females. The data also indicate that Ohio will need to aggressively promote 
cervical cancer screening to meet the 2020 goal of 93.0 percent of females receiving a Pap test 
in the last 3 years. 
Responsible Parties/Partners: 
•	 Ohio Breast and Cervical Program (BCCP) 
•	 Ohio Department of Health Reproductive Health and Wellness Program 
•	 Centers for Community Solutions 
•	 Planned Parenthood 
 
GOAL 9: Promote the Use of Cancer Genetic Services 
Background: 
Knowledge gained from family history and genetic testing can also play an important role in early 
detection. A detailed family history can help to identify an inherited predisposition for cancer and 
can guide people to an appropriate referral for genetic counseling and testing. Individuals who 
have an elevated risk for cancer based on family history or a genetic test will benefit from tailored 
advice about their options for prevention and surveillance. 
Objective 9.1: By December 31, 2014 provide 175 educational talks to Ohio healthcare 
professionals annually (about the established referral guidelines (NCCN, ACOG, NSGC) 
for cancer risk assessment. 
Supporting data: 
• Use the ODH education database to quantify the number of talks provided to professionals in
the state on cancer genetics and show an increase from 2011 to 2014 
(Baseline from 2010 = 163 talks to health care professionals). 
Strategy 9.1.1: Make referral criteria available to providers on ODH and Ohio Partners for 
Cancer Control (OPCC) websites and educate providers about these resources through 
mailing(s), and/or newsletters 
Strategy 9.1.2: Bi-annual collaboration with the Ohio Cancer Genetics Network to evaluate 
and update existing resources 
Strategy 9.1.3: Create, implement and promote continuing education (CE) opportunities for 
healthcare providers to expand awareness of the impact of family history and genetic factors 
on cancer risk by developing webinars or soliciting invitations to give presentations as a part of 
already established professional meetings 
Strategy 9.1.4: Approach healthcare degree granting programs (13 organizations) in Ohio 
beginning with large physician and physician assistants programs to discuss means for 
collaboration and in order to plan to more effectively integrate education about cancer 
genetics into their curriculum 
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Objective 9.2: By December 31, 2014 provide at least 95 outreach and education 
talks/events annually to enhance public knowledge about the impact of family 
history and genetics on cancer risk and management. 
Supporting data: 
•	 Use the ODH education database to quantify the number of lay talks provided in the state 
on cancer genetics and show an increase from 2011 to 2014 (Baseline from 2010 = 85 talks 
to lay public audiences). 
Strategy 9.2.1: Make information on underlying genetic and familial causes of common 
cancers, the importance of genetic counseling and early detection and cancer genetics 
services in Ohio more readily available to the public through the relevant websites 
such as OPCC and ODH/ Healthy Ohio, social media and patient-centered mailings and 
publications (i.e. emails/ mailings and postings on Facebook during family history and 
various cancer awareness months) 
Responsible Parties/Partners: OCGN 
Objective 9.3: By December 31, 2014 improve access to cancer risk assessment 
services, genetic testing and risk-appropriate management options. 
Supporting data: 
•	 Identify and increase the number of health plans in Ohio that have policies covering cancer 
genetic counseling and testing that are in alignment with the USPSTF guidelines. 
Strategy 9.3.1: Collaborate with OCGN, Ohio healthcare providers across disciplines and 
other relevant organizations to develop strategies to increase availability of screening and 
management for cancer as appropriate based on genetic risk and family history such as 
compilation of contact information for access to no-cost or low-cost screening services 
Strategy 9.3.2: Educate employers, health plan/ insurance personnel and policy makers 
on the importance of family history and genetics in the risk of cancer and to ensure 
development of appropriate criteria, coverage and policies for genetic counseling, genetic 
testing and management options 
Strategy 9.3.3: Support efforts to ensure that cancer genetics services are provided by 
qualified healthcare providers 
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Objective 9.4: By December 31, 2014 increase the number of moderate- and high-
risk individuals who receive appropriate cancer screening and referral for cancer 
genetic services to 3800 patients per year. 
Supporting data: 
•	 Use the Ohio Department of Health genetics database to quantify the numbers of patients 
seen for cancer genetics services in the state from 2011 to 2014 (Baseline from 2010: 3450 
patients received cancer genetic counseling) 
Strategy 9.4.1: Work with the Ohio Cancer Incidence Surveillance System to identify 
patients at high risk for hereditary cancer and notify the reporting physicians/hospitals 
Strategy 9.4.2: Educate healthcare providers about the implications of a cancer diagnosis 
for cancer risk among family members 
Strategy 9.4.3: Advocate for health insurance coverage of cancer risk assessment 
Strategy 9.4.4: Promote a family history cancer risk assessment tool for use in primary care 
settings 
Strategy 9.4.5: Create awareness campaigns regarding the importance of family history as 
a risk factor for cancer 
Responsible Parties/Partners: OCGN 
Objective 9.5: By December 31, 2014, develop and execute the Ohio Cancer 
Genetics Surveillance System, a population-based, state-wide, and web-based 
system to serve as a central depository for Hereditary Breast and Ovarian Cancer 
Syndrome and Colorectal Cancer Syndromes. 
Background: 
•	 Ohio has historically had a number of genomics-related data sources (the Ohio Cancer 
Incidence Surveillance System, and the Regional Genetic Center data reports); it is currently 
not possible to obtain detailed risk assessment information, specific cancer genetics-
related diagnosis, referral information, etc., at the state level. Ohio does not currently 
gather data regarding physician’s referrals to appropriate genetic services, according to 
established recommendations. Despite an interest by the genetic community in Ohio, 
there is no central depository of data/information on patients with cancer risks/diagnosis 
to assist genetic centers with grant applications, studies/clinical trials, and targeted 
education activities that could benefit individual patients and lead to improved public 
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• This system will be housed at the Ohio Department of Health. It will be based on
modifications to the MS ACCESS BRCA database developed in Michigan. The Michigan
Department of Health has generously agreed to share this ACCESS database with Ohio at no
cost. Although this database will be designed to duplicate the BRCA data fields collected in
Michigan, Ohio’s version will be enhanced to also collect information about patients seen for
colorectal cancer syndromes as well. It will be populated by information about patients seen
in programs who are partners in the Ohio Cancer Genetics Network (OCGN).
Strategy 9.5.1: Secure Ohio IT vendor to modify the ACCESS database into a web-based,
password-protected secure genetics data system housed on the ODH Gateway. This includes
an import routine to allow genetic assessment sites to submit files of patient data to populate
the data base.
Strategy 9.5.2: Work with vendor and OCGN to match Michigan BRCA data fields and add
colorectal cancer syndromes to the Ohio Cancer Genetics Surveillance System database
Strategy 9.5.3: Perform testing on system
Strategy 9.5.4: Dissemination to OCGN members with training on use
Responsible Parties/Partners: 
• ODH Genetics Program
• Ohio Cancer Genetics Network
• ODH Comprehensive Cancer Control Program
 
CLINICAL TRIALS AND RESEARCH
 
GOAL 10: Promote Clinical Trials 
Objective 10.1: By December 31, 2014, increase adult cancer patient enrollment in 
clinical trials at the 100 Commission on Cancer (CoC) accredited cancer programs 
by 2%. 2011 Baseline: 0-2% 
Data sources: CoC Accredited Cancer Programs 
Responsible Parties/Partners: CoC 
Strategy: 10.1.1 The CoC will require cancer programs that diagnose and treat 100-500 
or more cancer patients per year to accrue to clinical trials at a rate of 2%. The clinical trial 
accrual rate for larger cancer programs will be raised from current levels. 
Objective 10.2: By December 31, 2014 increase by 2% the adult cancer patient 
participation in clinical trials at select cancer programs in the Appalachian area 
of Ohio. 
Measure: Select Appalachian cancer programs capable of conducting clinical trials will be 
assessed as to their current clinical trial accrual percentages. The goal will be to increase clinical 
trial accrual by 2%. 
Data sources: Columbus Community Clinical Oncology Program, American Cancer Society 
Connection Data Base, and Commission on Cancer accredited cancer programs 
Responsible party/Partners: 
• Columbus Community Clinical Oncology Program
• CoC
Strategy 10.2.1: Access Columbus Community Clinical Oncology Data Base and American
Cancer Society Data Base to determine the number of Appalachian cancer programs
capable of participating in clinical trials
Strategy 10.2.2: Develop a program that assesses and addresses barriers to providing






















GOAL 11:	 Optimize the Quality of Life for Cancer Survivors and Significant Others 
through Community -Based Wellness Programs and Clinical Linkages 
Objective 11.1 By December 31, 2012 identify and engage at least 20 community-
based cancer wellness information outlets and psychosocial support services in 
Ohio to determine where gaps in service exist. 
Data Sources: American Cancer Society East Central Division (ACS), National Cancer Support 
Community Central Ohio 
Responsible Parties/Partners: 
• Ohio Department of Health (ODH) Comprehensive Cancer Control Program
• OPCC member representatives of community-based cancer wellness organizations, i.e.
o Cancer Support Community
o ACS
o Stewart’s Caring Place: Cancer Wellness Center
o The Gathering Place
• The Leukemia & Lymphoma Society
• Young Survival Coalition
Strategy 11.1.1: Establish a common definition of cancer specific wellness support
services using national resources; Establish what are essential services/resources
Strategy 11.1.2: Gather from the American Cancer Society data on cancer specific
wellness services in Ohio according to ZIP code and/or county
Strategy 11.1.3: Analyze and collate the data: What services
are provided in each location; what locations lack essential
services
Strategy 11.1.4: Assess a wellness organization’s ability
and willingness to provide essential services in adjacent
underserved areas by directly contacting the organization
Strategy 11.1.5: Ensure new programs or services are updated













Objective 11.2: By December 31, 2014 increase awareness of the importance and 
the availability of cancer specific community-based psycho-social and wellness 
services in Ohio to at least three regions of Ohio where gaps in service exist. 
Data Sources: ACS Connection Data Base, Program based evaluation, American College of 
Surgeons Commission on Cancer (CoC), Cancer Support Community Central Ohio
Responsible Parties/Partners: 
•	 ODH CCP 
•	 Cancer Support Community Central Ohio 
•	 CoC 
•	 ACS 
•	 College of Social Work, Ohio State University 
Strategy 11.2 .1: Refer cancer patients and families to the ACS National Cancer 
Information Center , 1-800-227-2345, available 24 hours a day, 365 days a year for access to 
local programs and services available to them 
Objective 11.3: By December 31, 2014, the ODH CCP program will collaborate 
with the Cancer Support Community Central Ohio to develop one demonstration 
project, to assess and facilitate the implementation of cancer specific psychosocial 
support services. 
Data Sources: American Cancer Society (Connection Database), Program based evaluation, 
CoC, Cancer Support Community Central Ohio. 
Responsible Parties/Partners: 
•	 ODH CCP 
•	 Cancer Support Community Central Ohio 
•	 CoC 
•	 ACS East Central Division 
•	 College of Social Work, Ohio State University. 
Strategy 11.3.1: Develop and disseminate a set of customizable evaluation modules (for 
use by, community based cancer specific psychosocial support service organizations) 
Strategy 11.3.2: Develop and facilitate a statewide “Yearly Meeting” of community based 
cancer specific psychosocial support service organizations 
Meeting agenda to include: 
o	 Strategic Planning Program development (round table discussion) 
o	 Successes/Opportunities: Networking opportunity 
o	 Communication Strategies—Distinguishing differences between national affiliates
and independent organizations 
o	 (Training Component) Evaluation Modules 
Strategy 11.3.3: In collaboration with community based specific psychosocial support 
service organizations and the Commission on Cancer, develop and disseminate a hospital-
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Objective 11.4: By December 31, 2014 encourage at least 10% of the 100 CoC 
accredited cancer programs in Ohio to implement a process to routinely assess and 
manage palliative care needs and psychosocial distress of a cancer patient on site or 
by referral. 
Measure: Baseline-0; Target-10% 
Data sources: CoC Data Base, Facility Information Profile System, ACS 
Timeframe: December 2014; Annual reporting 
Responsible Parties/Partners: CoC 
Strategy: 11.4.1: Assess the number of CoC accredited cancer programs in Ohio that 
provide palliative care and psychosocial distress assessment and support according to 
evidence based guidelines 
Strategy: 11.4.2: Assess the number of CoC accredited cancer programs in Ohio that 
provide psychosocial assessment and support according to evidence based guidelines 
Strategy: 11.4.3: Implement palliative care assessments and support on site or by referral as 
a CoC accredited requirement 
Strategy: 11.4.4: Implement psychosocial distress assessment and support on site or by 
referral as a CoC accreditation requirement 
Strategy: 11.4.5: Implement palliative care assessments and support on site or by referral as 
a CoC accredited requirement 
 
PALLIATIVE CARE/PSYCHOSOCIAL DISTRESS 
ASSESSMENT AND SUPPORT 
GOAL 12: Provide Essential Survivorship Management Tools and Services to  
Cancer Survivors. 
Objective 12.1: By December 31, 2014, increase to 25% the 100 CoC accredited 
cancer programs in Ohio that provide adult cancer patients with a portable summary 
of their diagnosis, treatment, subsequent follow-up requirements, possible sequellae, 
information about supportive services including genetic counseling. 
Measure: Baseline 0: 2014 Target 25% 
Data sources: Ohio Cancer Liaison Physicians, CoC Cancer Program Managers and Cancer 
Registrars 
Timeframe: Annual Reporting 
Responsible Parties/Partner: CoC State Chair 
Strategy: 12.1.1: Request, collect, and analyze cancer program data to obtain a baseline for 
the use of a personal health manager (portable health record) 
Strategy: 12.1.2: The CoC will implement the provision of a personal health manager file to 
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GOAL 13:	 Impact the Quality of Life of Cancer Patients by Providing American 
Cancer Society Information and Referral to National, Local and Community 
Resources, Programs, and Services. 
Objective 13.1: By December 31, 2014 increase automatic referrals to the American
Cancer Society from Ohio hospital based cancer programs serving over 1,000 cancer
patients a year and high numbers of under-served patients from 2011 baseline to 50%.
Measures: From 2011 baseline to 50% 
Data sources: ACS East Central Division 




Strategy 13.1.1: Utilize Multi-Tier Navigation Model to assist patients and families in accessing
programs and services available nationally, statewide and locally
Strategy 13.1.2: Engage CoC accredited 
hospitals by meeting with the Cancer 
Liaison Physician and attending the Cancer 
Committee Meetings 
Strategy 13.1.3: Provide cancer patients and 
caregivers availability to American Cancer 
Society supportive services such as Look Good 
Feel Better, I Can Cope and the on line web-
based Cancer Survivor Network 
Strategy 13.1.4: Provide cancer patient’s 
assistance with transportation to treatment or 













GOAL 14:	 Increase Interest in Cancer Surveillance, Prevention and Control 
Activities among State of Ohio Legislators and Organizational Policy 
Makers to Influence Policy and Systems Changes 
Objective 14.1: By December 31, 2012 establish a protocol by which the OPCC 
reviews and reaches decision regarding support for legislation impacting on cancer 
surveillance, prevention, and control. 
Objective 14.2: By December 31, 2014 attend and actively participate in the quar­
terly meetings of the Ohio General Assembly Cancer Caucus. 
Responsible Parties/Partners: 
•	 Easy Central Division 
•	 Ohio Department of Health 
•	 Ohio State University Medical Center 
•	 University Hospitals of Cleveland 
•	 Ohio State Medical Association 
Strategy 14.1.1: Actively engage in legislative, regulatory, and statewide policy initiatives 
that support the goals and objectives of The Ohio Cancer Prevention and Control Plan 
2011-2014 
Strategy 14.2.1: Seek out education opportunities to promote the goals and objectives of 
The Ohio Cancer Prevention and Control Plan 2011-2014 
Strategy 14.2.2: Conduct an annual advocacy day to educate the Administrators and 
Ohio General Assembly on the elements of The Ohio Cancer Prevention and Control Plan 
2011-2014 
Strategy 14.2.3: Provide periodic briefings to the Ohio General Assembly Cancer Caucus 
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Ohio Partners for Cancer Control
 
Participation Form – Yes, I Want to Be Involved!
 
The purpose of Ohio Partners for Cancer Control is to develop and implement The Ohio 
Comprehensive Cancer Control Plan 2011-2014. The partnership invites individuals and 
organizations with an interest in cancer prevention and control to participate in Ohio Partners 
for Cancer Control’s vision is “a cancer-free future for all Ohioans.” By completing this form, 
you will be added to the partnership’s mailing and email list and will be contacted by the 
Membership Committee. 
Name:______________________________________________________________________ 










Primary Prevention ❑ 
❑ 
❑ 
Early Detection Treatment and Care 
Research and Clinical Trials Palliation and Quality of Life Cancer Survivorship 
Data and Surveillance Other, please note: 
I know other individuals/organizations that might be interested in participating in Ohio
    Partners for Cancer Control. I recommend you contact: 
Name:_______________________________________________________________________ 
Phone/Email:__________________________________________________________________ 
Please fax this form to Ohio Partners for Cancer Control at 614-564-2409 or mail it to: 
Ohio Partners for Cancer Control 
246 North High 
Columbus, OH 43215 
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 Adena Health System  Erin Trapp 
 American Cancer Society East Central Division  Angie Hodges 
 American Cancer Society East Central Division  Anna Fetzer 
 American Cancer Society East Central Division  Ashley Russell 
 American Cancer Society East Central Division  LeighAnne Hehr 
 American Cancer Society, East Central Division  John Alduino 
 American Cancer Society, East Central Division  John Hoctor 
 American Cancer Society, East Central Division  Lynne Ayres 
 American College of Surgeons (MetroHealth)  Jean Stevenson 
 American College of Surgeons, Ohio Chapter  Valeriy Moysaenko 
 Appalachia Community Cancer Network  Darla Fickle 
 B.A.S.I.C. Circle  David Abdullah 
 Cancer Support Community Central Ohio  Skip Weiler 
 Cancer Support Community of Central Ohio  Bev Soult 
 Cancer Support Community of Central Ohio  Nina Lewis 
 Case Comp Cancer Center, Dept of Family Medicine  Susan Flocke 
 Case Comprehensive Cancer Center  Gabrielle Brett 
 Case Comprehensive Cancer Center  Stan Gerson 
 Case Western Univ., School of Medicine  Elizabeth McKinley 
 Christians Overcoming Cancer  Mary Jenkins 
 Cleveland Clinic Cancer Center at Fairview Hospital  Debra Pratt 
 Cleveland Clinic Cancer Center, Fairview  Jean Ellsworth-Wolk 
 Columbus Community Clinical Oncology Program  Carol Kuebler 
 Columbus Community Clinical Oncology Program  G.H. Rocky Haddix 
 Columbus Community Clinical Oncology Program  Sheree Oxley 
 Columbus Public Health  Fred Johnson 
 Dayton Clinical Oncology Program  Cara Nolan 
 Dayton Clinical Oncology Program  Sidney J. Pinkus 
 EISAI, Inc.  Todd Lacksonen 
 Genesis Healthcare System  Shannon White 
 Grant Medical Center  Fran Feehan 
 Hillcrest Hospital  Renata McBride 
 Individual - Survivor Advocate  Barbara Beckwith 
James Cancer Hospital - Diversity Enhancement/ 
 Ohio Breast and Cervical Cancer Coalition  Chasity Cooper 
 Kettering Medical Center  Tammy Dehaven-Fanz 
 Komen Northeast Ohio Affiliate  Carrie Clark 
 Leukemia and Lymphoma Society Phillip G. Tanner 
Midwest Care Alliance Jeff Lycan 
 NAACP  Michael W. McIntyre 
 National Association of Social Workers, Ohio Chapter  Danielle Smith 
 Northeastern Ohio Universities School of Public Health  John Petrus 
APPENDIX C 
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Northern Ohio Breast Cancer Coalition Fund 
Northwest Ohio Consortium for Public Health 
Ohio Academy of Family Physicians 
Ohio Assoc. of Physician Assistants 
Ohio Association of Community Health Centers 
Ohio Association of Free Clinics 








Ohio Cancer Genetics Network, Cleveland Clinic 
Ohio Cancer Registrar’s Association 
Ohio Commission on Minority Health 
Ohio Commission on Minority Health 
Ohio Commission on Minority Health 
Ohio Dental Association 
Ohio Department of Health 
Ohio Department of Health 
Ohio Department of Health 
Ohio Department of Health  
Ohio Department of Health 
Ohio Department of Health 
Ohio Department of Health 
Ohio Department of Health 
Ohio Department of Health 
Ohio Department of Health 
Ohio Department of Health 
Ohio Department of Health 
Ohio Dermatological Association 
Ohio Hispanic Coalition 
Ohio Hispanic Coalition 




Ohio Nurses Association 
Ohio Osteopathic Association 
Ohio Osteopathic Association 
Ohio Osteopathic Association 
Ohio Pain Initiative 
Ohio Pain Initiative 
Ohio Psychological Association 
Ohio Public Health Association 
Ohio Public Health Association 
Ohio State Association of Occupational Health Nurses 
Ohio State Medical Association 






























Ann R. Hudson 
Debbie Heidrich 
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 Ohio State University  James (Jay) Fisher 
 Ohio State University Comprehensive Cancer Center  Cathy Tatum 
 Ohio State University, School of Public Health  Janet S. DeMoor 
 Ohio/WVA Hematology Oncology Society  Dave Dillahunt 
OhioHealth Insurance-Ohio’  s Medicaid Program  Melissa Senter 
 OhioHealth Research Institute  Bill Hiermer 
 OhioHealth Research Institute  Melissa Thomas 
 Oncology Nursing Society  Ilene Comeras 
 OSU Comp Cancer Center - James Cancer Hospital  Stefanie Wesson 
 OSU Comprehensive Cancer Center-College of PH  Judy Harness 
 OSU Comprehensive Cancer Center-College of PH  Kristine Browning 
 OSU Comprehensive Cancer Center-College of PH  Mira Katz 
 OSU-James Cancer Hospital & Solove Research Institute  Jennifer Carlson 
 Ovarian Cancer Alliance of Ohio  Chris Gillespie 
 Premier Community Health  Roberta M. Taylor 
Stewart’  s Caring Place  Sarah Tower 
Stewart’  s Caring Place  Stacey Manes 
 Summa Health System  Marlo Schmidt 
 Survivor  Katherine Slaughter 
 Susan G. Komen for the Cure, Columbus  Megan Knapke 
 The Gathering Place  Ellen Heyman 
 The Gathering Place  Kristina Austin 
 University Hospital, Case Medical Center, Human Genetics  Duane Culler 
 University Hospitals Case Medical Center, Human Genetics  Georgia Weisner 
 University Hospitals Ireland Cancer Center  Hermione Malone 
 University of Cincinnati Cancer Center  John Perentesis 
 University of Cincinnati Cancer Center  Susan Waltz 
 Urban Mission  Frankie Myles 
 Wellness Community of Greater Cinci/N KY  Bonnie Crawford 
 Young Survival Coalition Central Ohio  Medha Sutliff 




ACOG American Congress of Obstetrics and Gynecologist 
ACS American Cancer Society 
ATS Adult Tobacco Survey 
BCCP Breast and Cervical Cancer Program 
BRFSS Behavioral Risk Factor Surveillance System 
CDBE Chronic Disease Behavioral Epidemiology 
CE Continuing Education 
CoC American College of Surgeons Commission on Cancer 
CPHSI Center for Public Health Statistics and Informatics 
CRC Colorectal Cancer 
DCBE Double Contrast Barium Enema 
FOBT Fecal Occult Blood Test 
HPV Human Papilloma Virus 
NCCN National Comprehensive Cancer Network 
NCHS National Center for Health Statistics 
NPCR National Program of Cancer Registries 
NSGC National Society of Genetics Counselors 
OCCCP Ohio Comprehensive Cancer Control Program 
OCGN Ohio Cancer Genetics Network 
OCISS Ohio Cancer Incidence Surveillance System 
ODH Ohio Department of Health 
ODJFS Ohio Department of Job & Family Services 
OH CBT Ohio Tobacco Cessation Benefits Team 
OMIS ODH Office of Management Information System 
OPCC Ohio Partners for Cancer Control 
SAS Statistical Analyses System 
SEER Surveillance, Epidemiology, and End Results 
The Warehouse Ohio Public Health Information Warehouse 
TUPCP Tobacco Use Prevention and Control Program 
USPSTF U.S. Preventive Services Task Force 
VS Ohio Vital Statistics 
YRBS Youth Risk Behavior Survey 
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